|
(1S)-1-(9-deazahypoxanthin-9-yl)-1,4-dideoxy-1,4-imino-D-ribitol-hydrochloride |
|---|---|
| Trade Name | |
| Orphan Indication | Hairy cell leukemia |
| USA Market Approval | USA |
| USA Designation Date | 2004-08-10 00:00:00 |
| Sponsor | Mundipharma Research Ltd.;Cambridge Science Park, Cambridge CB4 0GW; |
